Sue Wall Street digs into the scams, cover-ups, and corporate faceplants that Wall Street hopes you’ll ignore. From fraud and insider trading to the whistleblowers who called it out we break down how the powerful play the game and sometimes get burned. We’re not lawyers or accountants, so don’t take this as legal or financial advice. Go to ZLK.com for more on the case and follow us for the next corporate faceplant.
Dive into the Trip.com $TCOM controversy as we break down a securities class action tied to antitrust investigations, regulatory risk in China, and alleged misleading disclosures. This episode is for investors, traders, and anyone following tech platforms, global markets, and market volatility. Expect deep dives, real case analysis, and insights into regulatory scrutiny, risk disclosures, and stock drops.
Visit ZLK.com for more inf...
Dive into the Soleno Therapeutics $SLNO controversy as we break down a securities class action tied to drug safety, rare disease treatments, and alleged misleading statements around Vykat XR. This episode is for investors, traders, and anyone following biotech stocks, FDA approvals, and market risk. Expect deep dives, real case analysis, and insights into safety concerns, patient outcomes, and stock declines.
Visit ZLK.com for more...
Dive into the Oddity Tech $ODD controversy as we break down a securities class action tied to digital advertising, customer acquisition costs, and algorithm driven disruptions. This episode is for investors, traders, and anyone following ecommerce, tech stocks, and market risk. Expect deep dives, real case analysis, and insights into ad auction dynamics, rising costs, and sudden stock drops.
Visit ZLK.com for more info.
Add our Wha...
Dive into the Nektar Therapeutics $NKTR controversy as we break down a securities class action tied to biotech trials, protocol violations, and alleged misleading statements around clinical execution. This episode is for investors, traders, and anyone following biotech stocks, drug development, and market risk. Expect deep dives, real case analysis, and insights into trial integrity, statistical outcomes, and stock reactions.
Dive into the monday.com $MNDY controversy as we break down a securities class action tied to SaaS growth, enterprise sales trends, and shifting long term revenue targets. This episode is for investors, traders, and anyone following tech stocks, cloud platforms, and market volatility. Expect deep dives, real case analysis, and insights into slowing customer growth, longer sales cycles, and guidance cuts.
Visit ZLK.com for more info...
Dive into the Eos Energy $EOSE controversy as we break down a securities class action tied to battery technology, manufacturing automation, and missed revenue guidance. This episode is for investors, traders, and anyone following energy storage, clean tech, and market risk. Expect deep dives, real case analysis, and insights into production delays, downtime issues, and stock drops.
Visit ZLK.com for more info.
Add our WhatsApp Chan...
Dive into the Driven Brands $DRVN controversy as we break down a securities class action tied to financial restatements, internal control failures, and accounting errors across multiple years. This episode is for investors, traders, and anyone following earnings quality, corporate governance, and market risk. Expect deep dives, real case analysis, and insights into unreliable financials, audit issues, and stock crashes.
Visit ZLK.c...
Dive into the Camping World $CWH controversy as we break down a securities class action tied to inventory management, margin pressure, and alleged misleading statements about financial discipline. This episode is for investors, traders, and anyone following retail stocks, RV market trends, and market risk. Expect deep dives, real case analysis, and insights into inventory missteps, declining margins, and dividend cuts.
Visit ZLK.co...
Dive into the ChowChow Cloud $CHOW controversy as we break down a securities class action tied to IPO activity, alleged stock manipulation, and social media driven trading schemes. This episode is for investors, traders, and anyone following micro cap stocks, IPO risks, and market volatility. Expect deep dives, real case analysis, and insights into pump and dump patterns, low float risks, and sudden stock crashes.
Visit ZLK.com for...
Dive into the Boston Scientific $BSX controversy as we break down a securities class action tied to medical devices, electrophysiology growth, and alleged misleading statements around FARAPULSE adoption. This episode is for investors, traders, and anyone following healthcare stocks, medtech innovation, and market risk. Expect deep dives, real case analysis, and insights into competition, slowing procedure volumes, and stock drops.
Dive into the Aquestive Therapeutics $AQST controversy as we break down a securities class action tied to biotech approvals, FDA delays, and alleged misleading timelines around Anaphylm. This episode is for investors, traders, and anyone following biotech stocks, drug approvals, and market volatility. Expect deep dives, real case analysis, and insights into regulatory risk, clinical setbacks, and stock drops.
Visit ZLK.com for more...
Dive into the Apollo Global Management $APO controversy as we break down a securities class action tied to alleged undisclosed ties, reputational risk, and investor disclosures. This episode is for investors, traders, and anyone following hedge funds, Wall Street news, and market transparency. Expect deep dives, real case analysis, and insights into corporate governance, disclosure risks, and stock reactions.
Visit ZLK.com for more...
Dive into the Snowflake $SNOW controversy as we break down a securities class action tied to cloud computing, consumption based revenue, and unexpected growth headwinds. This episode is for investors, traders, and anyone following tech stocks, data platforms, and market volatility. Expect deep dives, real case analysis, and insights into pricing models, efficiency impacts, and stock drops.
Visit ZLK.com for more info.
Add our Whats...
Dive into the Navan $NAVN controversy as we break down a securities class action tied to IPO disclosures, rising sales and marketing costs, and post IPO stock declines. This episode is for investors, traders, and anyone following tech stocks, IPOs, and market risk. Expect deep dives, real case analysis, and insights into financial transparency, growth metrics, and investor expectations.
Visit ZLK.com for more info.
Add our WhatsApp...
Dive into the Lakeland Industries $LAKE controversy as we break down a securities class action tied to acquisitions, operational challenges, and missed financial guidance. This episode is for investors, traders, and anyone following industrial stocks, M and A strategies, and market risk. Expect deep dives, real case analysis, and insights into earnings misses, supply chain issues, and stock declines.
Visit ZLK.com for more ...
Dive into the Franklin BSP Realty Trust $FBRT controversy as we break down a securities class action tied to REIT dividends, commercial real estate debt, and alleged misleading statements about earnings power. This episode is for income investors, traders, and anyone following dividend stocks, REITs, and market risk. Expect deep dives, case analysis, and insights into dividend cuts, earnings pressure, and investor expectations.
Dive into the Corcept Therapeutics $CORT controversy as we break down a securities class action tied to biotech approvals, FDA setbacks, and alleged misleading statements حول relacorilant. This episode is for investors, traders, and anyone following biotech stocks, clinical trials, and market volatility. Expect deep dives, case analysis, and insights into FDA risk, insider selling, and stock crashes.
Visit ZLK.com for more info.
Dive into the Zynex $ZYXI controversy as we break down a massive securities class action tied to alleged overbilling, medical device supply practices, and inflated revenue growth. This episode is for investors, traders, and anyone following healthcare stocks, fraud allegations, and market risk. Expect deep dives, real case analysis, and insights into billing practices, regulatory scrutiny, and stock collapses.
Visit ZLK.com for mor...
Unpack the Enphase Energy $ENPH controversy as we break down a securities class action tied to solar energy, inventory management, and tax credit impacts. This episode is built for investors, traders, and anyone tracking clean energy stocks, earnings volatility, and market risk. We dive into safe harbor revenue, channel inventory concerns, and shifting guidance with sharp analysis and real case insights.
Visit ZLK.com for more info...
Dive into the NuScale Power $SMR controversy as we break down a high stakes securities class action involving nuclear energy, small modular reactors, and alleged misleading disclosures about key partner ENTRA1. This episode is for investors, traders, and anyone following energy stocks, clean energy, and stock market risk. Expect deep dives, case analysis, and sharp insights into financial reporting and investor transparency.
Visit ...
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
Saskia Inwood woke up one morning, knowing her life would never be the same. The night before, she learned the unimaginable – that the husband she knew in the light of day was a different person after dark. This season unpacks Saskia’s discovery of her husband’s secret life and her fight to bring him to justice. Along the way, we expose a crime that is just coming to light. This is also a story about the myth of the “perfect victim:” who gets believed, who gets doubted, and why. We follow Saskia as she works to reclaim her body, her voice, and her life. If you would like to reach out to the Betrayal Team, email us at betrayalpod@gmail.com. Follow us on Instagram @betrayalpod and @glasspodcasts. Please join our Substack for additional exclusive content, curated book recommendations, and community discussions. Sign up FREE by clicking this link Beyond Betrayal Substack. Join our community dedicated to truth, resilience, and healing. Your voice matters! Be a part of our Betrayal journey on Substack.
Ding dong! Join your culture consultants, Matt Rogers and Bowen Yang, on an unforgettable journey into the beating heart of CULTURE. Alongside sizzling special guests, they GET INTO the hottest pop-culture moments of the day and the formative cultural experiences that turned them into Culturistas. Produced by the Big Money Players Network and iHeartRadio.
The Clay Travis and Buck Sexton Show. Clay Travis and Buck Sexton tackle the biggest stories in news, politics and current events with intelligence and humor. From the border crisis, to the madness of cancel culture and far-left missteps, Clay and Buck guide listeners through the latest headlines and hot topics with fun and entertaining conversations and opinions.